BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7653332)

  • 1. The long term prophylaxis of affective disorders.
    Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN
    Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
    Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
    Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.
    Mauri MC; Laini V; Scalvini ME; Volonteri LS; Ferrari MS; Panza G
    Eur Rev Med Pharmacol Sci; 1999; 3(2):63-9. PubMed ID: 10827806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term lithium treatment of affective disorders. Long term effects and side effects].
    Hofmann G; Grünberger J; König P; Presslich O; Wolf R
    Psychiatr Clin (Basel); 1974; 7(3):129-48. PubMed ID: 4464541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of lithium carbonate in psychiatric therapy. Apropos of 85 cases].
    Darcourt G
    Psychopharmacologie; 1973; 0(0):26-42. PubMed ID: 4599704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the use of lithium to prevent recurrence of affective psychosis].
    Lange E; Heisig W; Felber W; König L
    Psychiatr Neurol Med Psychol (Leipz); 1989 Aug; 41(8):476-84. PubMed ID: 2813609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lithium level and interepisode functioning in bipolar disorder.
    Goodnick PJ; Fieve RR
    Am J Psychiatry; 1985 Jun; 142(6):761-2. PubMed ID: 4003601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder.
    Frank E; Kupfer DJ; Thase ME; Mallinger AG; Swartz HA; Fagiolini AM; Grochocinski V; Houck P; Scott J; Thompson W; Monk T
    Arch Gen Psychiatry; 2005 Sep; 62(9):996-1004. PubMed ID: 16143731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of prevention of endogenous affective diseases using lithium].
    Schou M
    Nervenarzt; 1974 Aug; 45(8):397-418. PubMed ID: 4214299
    [No Abstract]   [Full Text] [Related]  

  • 12. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder.
    Calabrese JR; Rapport DJ
    J Clin Psychiatry; 1999; 60 Suppl 5():5-13; discussion 14-5. PubMed ID: 10192402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.
    Maj M; Pirozzi R; Magliano L; Bartoli L
    Am J Psychiatry; 1998 Jan; 155(1):30-5. PubMed ID: 9433335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium carbonate in the treatment and prophylaxis of recurrent affective disorders: long term follow-up.
    Warick LH
    Bull Los Angeles Neurol Soc; 1970 Oct; 35(4):169-80. PubMed ID: 4990519
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.
    Chand PK; Mattoo SK; Sharan P
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):311-8. PubMed ID: 15149299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prophylactic effect of lithium salt in affective psychoses with special references to patients with therapeutic failures].
    Krzyzowski J; Skaryszewska J; Marcjan K
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():235-8. PubMed ID: 829629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium prophylaxis in recurrent affective illness.
    Prien RF; Klett CJ; Caffey EM
    Am J Psychiatry; 1974 Feb; 131(2):198-203. PubMed ID: 4587809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.